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Experimental results have suggested that transgene expression can be saturated when large 
amounts of plasmid vectors are delivered into cells. To investigate this saturation kinetic 
behavior, cells were transfected with monitoring and competing plasmids using cationic 
liposomes. Even although an identical amount of a monitoring plasmid expressing firefly 
luciferase was used for transfection, transgene expression from the plasmid was greatly affected 
by the level of transgene expression from competing plasmids expressing renilla luciferase. 
Similar results were obtained by exchanging the monitoring and competing plasmids. The 
competing plasmid-dependent reduction in transgene expression from the monitoring plasmid 
was also observed in mouse liver after hydrodynamic injection of plasmids. On the other hand, 
the mRNA and protein expression level of GAPDH, an endogenous gene, in the liver hardly 
changed even when transgene expression process is saturated. The expression of firefly 
luciferase from a monitoring plasmid was significantly restored by siRNA-mediated degradation 
of renilla luciferase mRNA that was expressed from a competing plasmid. These results suggest 
that the efficiency of protein synthesis from plasmid vectors is reduced when a large amount of 
mRNA is transcribed with no significant changes in endogenous gene expression. 




Development of efficient gene delivery methods is needed not only for gene therapy but also for 
the functional studies of genes. Of the various vectors and gene delivery/transfer methods 
developed thus far, rapid injection of naked plasmid DNA in a large volume of isotonic solution, 
the so-called the hydrodynamic injection method, is one of the most effective and promising 
gene delivery methods because of its simplicity, reproducibility and high efficiency (Herweijer 
and Wolff 2007; Kobayashi et al. 2005; Lewis and Wolff 2007; Liu et al. 1999). Therefore, this 
gene delivery technique has frequently been used as an experimental tool to investigate the gene 
of interest in mouse liver, the organ that most efficiently expresses the gene products after 
hydrodynamic delivery of naked plasmid DNA.  
In a previous study, we found, using a firefly luciferase-expressing plasmid DNA, that the 
level of luciferase activity in mouse liver increased in parallel with the increasing dose of the 
plasmid up to about 1 µg DNA/mouse (Kobayashi et al. 2004). However, we also noticed that the 
luciferase activity reached a plateau at doses around 10 μg DNA/mouse, suggesting that the 
transgene expression from plasmid DNA is saturated at such high doses. These experimental 
results could be explained by assuming the presence of one or more saturable processes in the 
transgene expression after hydrodynamic delivery of plasmid DNA to mouse liver. One obvious 
possibility is that the amount of plasmid DNA delivered to the nucleus of transfected cells is not 
proportional to the increasing dose of the DNA. However, this can be rejected by the previous 
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finding that 20 μg empty plasmid co-administered had no significant effect on the level of 
transgene expression from 0.2 μg luciferase-expressing plasmid (Kobayashi et al. 2004). The 
empty plasmid used contained the same promoter/enhancer and other components as those in the 
luciferase-expressing plasmid except for the cDNA region. Therefore, these results strongly 
support the hypothesis that the efficiency of the cellular uptake and intracellular trafficking of 
plasmid DNA, including the nuclear entry, is not a function of the amount or concentration of the 
DNA, even although several reports have indicated that transcription factors and other proteins 
were involved in the nuclear entry of plasmid DNA microinjected into the cytosol (Dean 1997; 
Dean et al. 1999; Miller and Dean 2008).  
There are several steps in the process of transgene expression, including RNA synthesis 
(transcription), RNA modification (splicing), export of mRNA from the nucleus into the cytosol, 
protein synthesis (translation), post-translational modification of protein and transport/trafficking 
of protein. Considering the fact that all these steps in the gene expression are capacity-limited, it 
is reasonable that transgene expression becomes saturated when a large amount of DNA is 
introduced into cells. In good agreement with this hypothesis, saturation in transgene expression 
has been discussed in several studies involving transgene expression in cultured cells. Tachibana 
et al. investigated the relationship between the dose of plasmid DNA added to cells and the 
amount of transgene product (Tachibana et al. 2002). They showed that the copy number of 
plasmid DNA in the nucleus correlated with its dose. Furthermore, they demonstrated that the 
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copy number in the nucleus did not correlate with the amount of transgene product, especially 
when the copy number was high. A recent study by Cohen et al. also showed that nuclear uptake 
of plasmid DNA was linearly related to its dose whereas the level of transgene expression was 
not (Cohen et al. 2009). Carpentier et al. investigated the limiting factors involved in the process 
of transgene expression (Carpentier et al. 2007). They found that both transcriptional and 
translational processes were saturated under optimal transfection conditions in which quite a high 
level of gene expression was obtained. These previous studies strongly suggest that transgene 
expression can be saturated under certain conditions.  
Detailed understanding of this saturable mechanism of transgene expression from plasmid 
vectors will provide new insights into how gene expression is regulated in cells. The 
understanding could also lead to the development of methods to achieve high level of transgene 
expression without saturation. In addition, from the viewpoint of safety, it is important to 
investigate whether endogenous gene expression is affected when transgene expression process 
is saturated, because it may cause unexpected side effects, such as cell death. For example, Lin et 
al. reported that adenoviral vector-mediated high transgene expression of serum response factor 
resulted in nonspecific reduction of transcription of endogenous genes and caused cell death (Lin 
et al. 2007). Therefore, in the present study, we examined whether the synthesis of transgene 
products is actually saturated when a large amount of plasmid DNA is delivered to cells. To this 
end, cultured cells were transfected with two types of plasmid vectors, each of which encodes a 
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reporter protein, and transgene expression from the vectors was used to investigate whether the 
expression from one plasmid (monitoring plasmid) is affected by that from the other plasmid 
(competing plasmid). Then, similar experiments were carried out using mice that received a 
hydrodynamic injection of the two plasmid vectors. In addition, the mRNA and protein levels of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mouse liver were evaluated as a model 
endogenous gene to evaluate the effect of transgene expression on endogenous gene expression. 
Small interfering RNA (siRNA) was used to reduce the amount of mRNA without altering the 
amount of plasmids for transfection.  
 
MATERIALS AND METHODS 
 
Plasmid DNA and siRNA  
Salmon testes DNA (stDNA) was purchased from Sigma (St Louis, MO, USA). Plasmid DNA 
encoding firefly luciferase (FL) under the control of CMV promoter (pFL-CMV) was 
constructed as described previously (Nomura et al. 1999). The following plasmids were 
purchased from the sources in brackets: pGL3-control vector (Promega, Madison, WI, USA), 
pLuc-mcs (Stratagene, La Jolla, CA, USA), pRL-CMV (Promega) encoding renilla luciferase 
(RL) under the control of CMV promoter, pRL-SV40 (Promega), pRL-TK (Promega), pEGFP-F 
(BD Biosciences Clontech, Palo Alto, CA, USA) encoding farnesylated enhanced green 
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fluorescent protein (GFP) under the control of CMV promoter. These plasmids were renamed 
according to the cDNA and promoter of each plasmid as follows: pFL-SV40, pFL-TATA, 
pRL-CMV, pRL-SV40, pRL-TK and pGFP-CMV. siRNA targeting renilla luciferase mRNA 
(siRL) or GFP mRNA (siGFP) was purchased from Takara Bio (Otsu, Japan). Target sites in the 
renilla luciferase and GFP mRNA are as follows: renilla luciferase, 
5′-GUAGCGCGGUGUAUUAUAC -3′; GFP, 5′-GGCUACGUCCAGGAGCGCA-3′.  
 
Cell culture 
A murine melanoma cell line, B16-BL6, was obtained from the Cancer Chemotherapy Center of 
the Japanese Foundation for Cancer Research (Poste et al. 1980). B16-BL6 cells were cultured in 
Dulbecco’s modified Eagle’s minimum essential medium (Nissui Pharmaceutical, Tokyo, Japan) 
supplemented with 10% fetal bovine serum and penicillin (100 U/ml)/streptomycin (100 
μg/ml)/L-glutamine (2 mM) at 37 °C and 5% CO2.  
 
In vitro transfection  
B16-BL6 cells were plated on 24-well culture plates at the density of 2×104 cells/well. After an 
overnight incubation, transfection of plasmid DNA was carried out using Lipofectamine 2000 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. In brief, 1 µg of 
nucleic acids (plasmids with or without siRNA), was mixed with 3 µg Lipofectamine 2000 in 
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Opti-MEM I (Invitrogen) at a final concentration of 6 µg Lipofectamine 2000/ml. The resulting 
complex was added to cells and the cells were incubated with the complex for 4 hr. Then, cells 
were washed with PBS and further incubated with the culture medium.  
 
Luciferase assay in B16-BL6 cells  
B16-BL6 cells were lysed using the cell lysis buffer of an assay kit (PiccageneDual, Toyo Ink, 
Tokyo, Japan). Then, samples were mixed with the kit luciferase assay buffer, and the 
chemiluminescence produced was measured in a luminometer (Lumat LB9507, EG and G 
Berthold, Bad Wildbad, Germany). The luciferase activities were converted to the amount of 
firefly and renilla luciferase using recombinant proteins as the standard. 
 
Flow cytometric analysis of GFP expression in B16-BL6 cells  
B16-BL6 cells were transfected with pGFP-CMV as described above. One day after transfection, 
adherent cells were detached by trypsinization and resuspended in PBS. Resuspended cells were 
analyzed on a flow cytometer (FACSCan, BD, Franklin Lakes, NJ, USA). The threshold on FSC 
was set to exclude cell debris without excluding any populations of interest.  
 
mRNA quantification in B16-BL6 cells  
One day after transfection, total RNA was extracted from cells using Sepasol RNA I super 
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(Nacalai Tesque, Kyoto, Japan). Following RNase-free DNase I treatment (Takara Bio), reverse 
transcription was performed using a SuperScript II (Invitrogen) and dT-primer according to the 
manufacturer’s protocol. For a quantitative analysis of mRNA expression, real-time PCR was 
carried out with total cDNA using a Light-Cycler instrument (Roche Diagnostics, Basle, 
Switzerland) as reported previously (Takahashi et al. 2005). The mRNA expression of target 
genes was normalized using the mRNA level of GAPDH. 
 
Animal experiments  
Four-week-old male ICR mice (approximately 20g body weight), purchased from Japan SLC, 
Inc. (Shizuoka, Japan) were used for all experiments. The protocols for animal experiments were 
approved by the Animal Experimentation Committee of the Graduate School of Pharmaceutical 
Sciences of Kyoto University. Mice received an intravenous injection of plasmid DNA by the 
hydrodynamic injection method as described previously (Liu et al. 1999). At 6 hr after gene 
transfer, the peak time of the expression of firefly and renilla luciferases from the plasmid 
vectors used, the mice were killed by cervical dislocation and the amount of luciferase mRNA 
and protein in the liver was determined as described below.  
 
Quantification of the amounts of luciferase and GAPDH in mouse liver  
The liver was excised and homogenized in a lysis buffer (0.1 M Tris (pH 7.8), 0.05% Triton 
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X-100, 2 mM EDTA, 0.1 % protease inhibitor cocktail (Sigma)), and centrifuged at 13000 g for 
20 min at 4 °C. The amount of luciferase in the supernatant was determined by the method 
described in the above section. The amount of GAPDH protein in the lysate was measured by 
ELISA by using a commercial kit (GAPDH Whole-cell Normalization kit, Active Motif, 
Carlsbad, CA). 
 
mRNA quantification in mouse liver  
Total RNA was extracted from approximately 50 mg liver samples using Sepasol RNA I Super. 
After purification of the extracted RNA sample using an RNeasy mini kit (Qiagen), reverse 
transcription and real-time PCR analysis were performed as described in the above section. 
 
Statistical analysis  
The normality of the data was evaluated by using Shapiro-Wilk test. Data of normal distribution 
were analyzed by Student’s t-test for two independent samples or one-way analysis of variance 
(ANOVA) followed by the Tukey’s test for multiple comparisons. Data without normal 
distribution were analyzed using Mann-Whitney rank sum test for two independent samples or 
Kruskal-Wallis one-way ANOVA on ranks followed by the Tukey’s test for multiple comparisons. 




Time-course and dose-dependent luciferase expression in B16-BL6 cells.  
Fig. 1A shows the time-courses of the amounts of firefly and renilla luciferases in cells after 
cotransfection with pFL-CMV and pRL-CMV. The expression of both luciferases was detectable 
as early as 6 hr after transfection, reached maximum values at 24 hr and then eventually 
decreased with time. As the highest luciferase expression was detected at 24 hr after transfection 
under the conditions used, this time point was selected and used in the following experiments to 
examine transgene expression in B16-BL6 cells.  
Fig. 1B shows the amount of firefly luciferase in cells transfected with different amounts of 
pFL-TATA, pFL-SV40 or pFL-CMV. pFL-CMV showed the highest firefly luciferase, followed 
by pFL-SV40, then pFL-TATA, reflecting the strength of these promoters used. When cells were 
transfected with one of the renilla luciferase-expressing plasmid DNA, pRL-CMV showed the 
highest renilla luciferase activity, followed by pRL-SV40 and pRL-TK (data not shown).  
To statistically evaluate whether the expression is saturated with an increasing amount of 
plasmid DNA, the expression efficiency was estimated by dividing the luciferase activity by the 
dose (Fig. 1C). The value was about 40,000 pg/well/µg plasmid DNA at the lowest dose of 
0.0002 µg/ml pFL-CMV. Increasing the dose to 2 μg/ml significantly reduced the value to 5,000 
pg/well/µg plasmid DNA.  
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Luciferase expression in B16-BL6 cells transfected with two different plasmids.  
Fig. 2 shows the amounts of firefly (Fig. 2A) and renilla luciferase (Fig. 2B) in cells 24 hr after 
cotransfection with 1.8 μg/ml pFL-TATA, pFL-SV40 or pFL-CMV and 0.2 μg/ml pRL-TK, 
pRL-SV40 or pRL-CMV. The amount of firefly luciferase was the highest in cells transfected 
with pFL-CMV, which was about 4- and 20-fold higher than that in cells transfected with 
pFL-SV40 or pFL-TATA, respectively. In all cases examined, the amount of firefly luciferase 
was hardly affected by the cotransfection with renilla-expressing plasmid DNA (Fig. 2A). This 
was probably because the dose of the renilla luciferase-expressing plasmid DNA was only a tenth 
of the total amount of plasmids used for transfection. In marked contrast, the renilla luciferase 
activity in B16-BL6 cells was affected not only by the type of renilla luciferase-expressing 
plasmid DNA, but also by the type of competing, firefly luciferase expressing plasmid DNA (Fig. 
2B). Renilla luciferase activity in cells transfected with pRL-CMV and pFL-CMV 
(pRL-CMV/pFL-CMV) or pRL-SV40/pFL-CMV was significantly lower than that in cells 
transfected with pRL-CMV/pFL-TATA or pRL-SV40/pFL-TATA, respectively. The amount of 
renilla luciferase in B16-BL6 cells transfected with pRL-TK was quite low compared with cells 
transfected with pRL-CMV or pRL-SV40. 
Similar experiments were performed using 0.2 μg/ml firefly luciferase-expressing plasmid 
DNA and 1.8 μg/ml renilla luciferase-expressing plasmid DNA (Fig. 2C and D). The amount of 
firefly luciferase in cells cotransfected with pFL-CMV/pRL-CMV was significantly lower than 
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that in cells cotransfected with pFL-CMV/pRL-TK (Fig. 2C). Again, the amount of renilla 
luciferase was hardly affected by the type of firefly luciferase expressing plasmid vectors 
cotransfected (Fig. 2D).  
 
Fluorescent histogram of GFP in B16-BL6 cells transfected with pGFP-CMV and renilla 
luciferase-expressing plasmid.  
Fig. 2E shows typical histograms of the fluorescence intensity of B16-BL6 cells transfected with 
pGFP-CMV and one of the following plasmids: pRL-CMV, pRL-SV40 or pRL-TK. In all cases 
examined, there was a large variation in the level of fluorescence intensity of B16-Bl6 cells 
transfected with pGFP-CMV. There were no obvious differences in the histograms of cells 
transfected with pGFP-CMV/pRL-TK or pGFP-CMV/pRL-SV40. On the other hand, the 
histogram of cells transfected with pGFP-CMV/pRL-CMV was different from the others; the 
percentage of cells with a high fluorescence intensity (the M1 region in the histogram) was 3 %, 
and this value was smaller than the 8 and 9 % for the pGFP-CMV/pRL-SV40- and 
pGFP/pRL-TK-treated cells, respectively. These findings indicate that cotransfection of cells 
with pRL-CMV, the plasmid with the strongest promoter among those used, markedly reduced 
the expression of GFP from pGFP-CMV only in cells that received efficient delivery of these two 
plasmids. In accordance with these histograms, the mean fluorescence intensity of cells 
transfected with pGFP-CMV/pRL-CMV was significantly lower than that of cells transfected 
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with pGFP-CMV/pRL-TK or pGFP-CMV/pRL-SV40 (Fig. 2F).  
 
mRNA and protein expression level of luciferases in B16-BL6 cells transfected with two 
different plasmids.  
The mRNA level was measured in B16-BL6 cells transfected with two types of plasmids, each of 
which expressed firefly or renilla luciferase. Again, cells were transfected with 0.2 μg/ml 
pFL-CMV and 1.8 μg/ml renilla luciferase-expressing plasmid, and the mRNA and luciferase 
activity were simultaneously measured at 24 hr after transfection (Fig. 3). The amount of renilla 
luciferase protein was dependent on the type of plasmids used as described above, but it was 
almost proportional to its mRNA level in all cases (Fig. 3A). The amount of firefly luciferase 
protein was highly dependent on the type of renilla luciferase-expressing plasmid cotransfected 
(Fig. 3B), as shown in Fig. 2B. Moreover, the mRNA level of firefly luciferase was also affected 
by other plasmids in a manner dependent on the promoter strength (Fig. 3B), suggesting that 
some processes leading to mRNA expression are saturated in cells that produce a large amount of 
mRNA. In addition, the degree of reduction in firefly luciferase mRNA by cotransfection with 
pFL-CMV/pRL-CMV (about 20 % of pFL-CMV/pRL-TK) was less than that of firefly luciferase 
protein (about 8 %), which implies that the amount of firefly luciferase protein was 
disproportionate to its mRNA level. 
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Luciferase expression in B16-BL6 cells transfected with siRNA and plasmids.  
The results obtained thus far are consistent with the hypothesis that the synthesis of protein from 
mRNA is saturated when a large amount of mRNA is transcribed, and this leads to 
disproportionate protein synthesis to the mRNA level. To confirm this hypothesis, we degraded 
the mRNA of renilla luciferase using siRL, an siRNA targeting renilla luciferase, and measured 
the amount of luciferase proteins. For this purpose, B16-BL6 cells were cotransfected with 1 
μg/ml siRL or siGFP, a control siRNA, in addition to 0.9 μg/ml pRL-CMV, pRL-SV40 or 
pRL-TK and 0.1 μg/ml pFL-CMV. As expected, the amount of renilla luciferase was markedly 
suppressed in cells transfected with siRL compared with siGFP (Fig. 4A), which suggests that 
siRL successfully degraded the target mRNA under these experimental conditions. 
Cotransfection of siRL significantly increased the amount of firefly luciferase in B16-BL6 cells 
transfected with pRL-CMV/pFL-CMV (Fig. 4B). These results suggest that siRNA-mediated 
degradation of mRNA from competing plasmids is effective in restoring transgene expression 
from the monitoring plasmid. However, the firefly luciferase expression in the cells transfected 
with siRL, pFL-CMV and pRL-CMV was lower than that of the cells transfected with siRL, 
pFL-CMV and pRL-TK. 
 
Dose-dependent mRNA and protein expression of luciferase in mice after 
hydrodynamics-based administration and its effect on GAPDH expression.  
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Fig. 5A shows the amounts of mRNA and protein of firefly luciferase in mouse liver 6 hr after 
hydrodynamic injection of pFL-CMV at different doses. Results were normalized to those of 
mice that received 1 µg/mouse pFL-CMV administration. A linear correlation was observed 
between the firefly luciferase mRNA and the plasmid dose over the dose range investigated, i.e., 
from 1 to 300 µg/mouse. At the dose of 10 µg/mouse, the relative amount of luciferase protein 
was comparable with that of mRNA expression, indicating that the efficiency of protein synthesis 
from mRNA was similar at doses of 1 and 10 µg/mouse. However, at a dose of 30 µg/mouse or 
higher, the ratio of firefly luciferase protein to its mRNA was smaller than at the low doses. Thus, 
these results indicate that the amount of luciferase protein becomes disproportionate to the 
amount of its mRNA in mouse liver, when the mRNA level is increased. Then, the mRNA and 
protein amounts of firefly luciferase were divided by the dose, and the values obtained were used 
to evaluate the efficiency or saturation of the expression. The efficiency of mRNA expression 
was not significantly affected by the dose, whereas that of protein expression significantly 
decreased with an increase in the dose of plasmid DNA. 
To evaluate whether endogenous gene expression process is affected by large amount of 
mRNA expressed from plasmid vectors, the mRNA and protein expression of firefly luciferase 
and GAPDH in mouse liver were simultaneously measured 6 hr after hydrodynamic 
administration of 0 µg, 1 µg or 100 µg pFL-CMV (Fig. 5B). As is the case of the experiment 
above, the difference in mRNA amount of firefly luciferase between 1 µg and 100 µg was bigger 
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than that in protein amount, which suggests the existence of saturation of protein synthesis 
process of transgene. No significant changes in GAPDH mRNA and protein expression were 
observed among all treatment group despite the fact that transgene expression process was 
saturated.  
 
mRNA and protein expression of luciferases in mouse liver after hydrodynamic injection of 
naked plamid vectors.  
Finally, mice received a hydrodynamic injection of 1 μg pRL-CMV and 10 μg pFL-CMV, 
pFL-SV40 or pFL-TATA, and the levels of mRNA and protein were simultaneously measured 
(Fig. 5C and D). The amount of firefly luciferase was dependent on the strength of promoter and 
proportional to its mRNA level (Fig. 5C). The mRNA level of renilla luciferase was almost the 
same in all cases (Fig. 5D), reflecting the fact that the same amount of pRL-CMV was used for 
hydrodynamic injection. In contrast, the amount of renilla luciferase protein in the liver of mice 
receiving pRL-CMV/pFL-CMV was significantly lower than that of mice receiving 
pRL-CMV/pFL-TATA (Fig. 5C). 
 
DISCUSSION 
Transgene expression from monitoring plasmid was reduced by cotransfection with competing 
plasmid driven by a strong promoter and this phenomenon was independent of the type of cDNA 
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encoded in the monitoring and competing plasmids (Fig. 2). These results suggest that saturation 
of transgene expression is not dependent on the type of transgene product. In the experiment 
using pGFP-CMV, cells with a very high fluorescence intensity, which was found after 
cotransfection of cells with pRL-SV40 or pRL-TK, were not detected when cells were 
cotransfected with pRL-CMV. The cells with high fluorescence intensity should have been 
delivered with a large amount of pGFP-CMV and, therefore, they could have also efficiently 
taken up coexisting plasmids. Therefore, it is reasonable to suggest that transgene expression is 
saturated especially in cells that encounter a large amount of plasmid DNA. Although the both 
experiments exhibited a similar trend, the degree of the reduction by co-transfection with 
pRL-CMV was much less in the GFP experiment than that in the luciferase experiment. The 
discrepancy may be explained by the difference in the detection sensitivity of GFP and luciferase 
expression. 
Transgene expression from plasmid DNA requires a number of processes, such as delivery of 
plasmid DNA to the nucleus, mRNA transcription from the DNA, export of mRNA from the 
nucleus, processing of mRNA, translation, and post-translational modification of protein. In the 
present study, we found that the level of mRNA and protein expression from monitoring 
plasmids was affected by the type of competing plasmids cotransfected in B16-BL6 cells (Fig. 3). 
Moreover, co-transfection of siRL with pFL-CMV (monitoring plasmid) and pRL-CMV 
(competing plasmid) significantly rescued firefly luciferase protein expression compared with 
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the co-transfection of siGFP with pFL-CMV and pRL-CMV. These experimental results suggest 
for the first time that the translational process is highly likely to be saturated when a large 
amount of protein is produced. A careful comparison of the results showed that firefly luciferase 
expression in the cells transfected with pFL-CMV was lower when cells were cotransfected with 
siRL and pRL-CMV than that with siRL and pRL-TK. As renilla luciferase amount of the 
siRL/pFL-CMV/pRL-CMV group was much higher than that of the siRL/pFL-CMV/pRL-TK 
group, a simple explanation is that siRL-mediated reduction in renilla mRNA was not enough to 
completely rescue the firefly luciferase expression. We found a reduced mRNA expression of 
firefly luciferase in the pFL-CMV/pRL-CMV group compared to the pFL-CMV/pRL-TK group 
(Fig.3B). In addition, siRNA degrades its target mRNA in the cytoplasm so that siRNA does not 
affect the earlier processes such as transcription. Therefore, the siRL-mediated incomplete rescue 
of firefly luciferase protein expression may suggest that not only translation but also the earlier 
processes such as transcription are also saturated under the experimental conditions used.  
The studies using mice led to a slightly different conclusion. Transgene expression was also 
saturated when a large amount of plasmid DNA was delivered, but the transcription was hardly 
affected by the dose (Fig. 5A). Therefore, the translational process is likely to be saturated in 
mouse liver (Fig. 5C and D), which is different from the in vitro results. This apparent 
discrepancy might be due to the difference in the type of transgene-expressing cells or in the 
delivery method of plasmid DNA. Further studies are needed to identify factors explaining the 
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discrepancy. The firefly gene sequence in pFL-CMV was not fully codon-optimized for 
expression in mice and 5 % of the codons in the sequence are ones with low frequency (< 30%) 
in mice, so this could be a bottleneck during translation. To our knowledge, no previous study 
has reported the saturation of transgene expression processes in vivo. Our finding agrees with the 
results of Carpentier et al (Carpentier et al. 2007). They found that transcriptional and 
translational processes are saturated under optimal transfection conditions in which cells were 
very efficiently transfected with plasmids. In addition, they reported that the translational process 
is saturated at a dose of plasmid DNA that does not affect the transcriptional process. In the 
present study, we found that transgene expression process can be saturated when the large 
amount of plasmid DNA is delivered to mouse liver by hydrodynamic injection. We and others 
also found a similar phenomenon in lipoplex-mediated and polyplex-mediated transfection of 
cultured cells, where the mode of gene delivery is different from the hydrodynamic injection 
(Carpentier et al. 2007). In addition, it has been reported that there is a saturation in secretory 
pathway after the transfection by adenoviral vectors encoding secretory proteins (Marmostein et 
al. 2000) Therefore, we believe that transgene expression could be saturated when cells are 
transfected using gene vectors with strong promoters. 
When the transcription of endogenous genes is inhibited by adenovirus vectors because of the 
sharing of transcription factors, the expression of endogenous genes was inhibited at the mRNA 
level, and cells were damaged (Lin et al. 2007). As we observed saturation in the translational 
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process, but not in the transcriptional process, this ‘promoter squelching’ will not be the case. 
Regarding toxicity, we did not observe any B16-BL6 cell death at 24 hr after transfection. As an 
earlier study by Lin et.al reported that cellular toxicity by promoter squelching was observed at 
48 and 72 hr after transfection but not at 24 hr after transfection, any toxicity in B16-BL6 cells 
might be observed at later time points. At least 6hr after the hydrodynamic delivery of plasmid 
DNA, no changes in the mRNA and protein amount of model endogenous gene, GAPDH, was 
observed. In addition, no damage was observed in the liver of mice at 6 hr after hydrodynamic 
injection. In the case of hydrodynamic gene transfer, peak time of the transgene expression is 
usually about 6-24 hr and transgene expression level declines after the peak time. Therefore, 
transgene expression after hydrodynamic gene delivery is considered to be not long enough to 
affect endogenous gene expression.  
In conclusion, we demonstrated that the transgene expression process can be saturated both in 
cultured cells and in mouse liver and that translation is a major process that can be saturated in 
transgene expression. Therefore, such an approach that can potentiate the gene expression 
processes of cells such as transcription and translation would be desirable to achieve higher gene 
expression if the delivery efficiency is high enough to saturate gene expression machinery. 
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Fig.1. Time- and dose-dependent luciferase expression in B16-BL6 cells after transfection of 
luciferase-expressing plasmid DNA. A. The firefly (closed symbols) and renilla (open symbols) 
luciferase activities were measured at indicated times after transfection of B16-BL6 cells with 1 
μg/ml pFL-CMV and 1 μg/ml pRL-CMV. The results are expressed as the mean ± SD (n = 4). B. 
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The luciferase activity was measured at 1 day after transfection of B16-BL6 cells with the 
indicated dose of pFL-CMV (open triangle), pFL-SV40 (open circle) or pFL-TATA (closed 
circle). The results are expressed as the mean ± SD (n = 3). C. The amount of firefly luciferase 
protein in Fig. 1B was divided by the dose of plasmid DNA. The results are expressed as the 
mean ± SD of the relative value to that of 0.0002 μg/ml (pFL-CMV and pFL-SV40) or to that of 
0.002 μg/ml (pFL-TATA) (n = 3). 
 
Fig.2. Effect of the level of transgene expression from competing plasmid DNA on 
transgene expression from monitoring plasmid DNA. A & B. B16-BL6 cells were 
cotransfected with 1.8 μg/ml pFL-TATA (closed bar), pFL-SV40 (open bar) or pFL-CMV (grey 
bar) and 0.2 μg/ml pRL-TK (closed bar), pRL-SV40 (open bar) or pRL-CMV (grey bar). One 
day after transfection, firefly (A) and renilla (B) luciferase activities were simultaneously 
measured. The results are expressed as the mean ± SD (n = 4). *P < 0.05, compared with the 
pFL-TATA-transfected group. C & D. B16-BL6 cells were cotransfected with 1.8 μg/ml pRL-TK 
(closed bar), pRL-SV40 (open bar) or pRL-CMV (grey bar) and 0.2 μg/ml pFL-TATA (closed 
bar), pFL-SV40 (open bar) or pFL-CMV (grey bar). One day after transfection, firefly (C) and 
renilla (D) luciferase activities were simultaneously measured. The results are expressed as the 
mean ± SD (n = 4). *P < 0.05 (vs pRL-TK transfected group). E & F B16-BL6 cells were 
cotransfected with 1.8 μg/ml pRL-CMV (line with shade), pRL-SV40 (bold line) or pRL-TK 
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(solid line) and 0.2 μg/ml pGFP-CMV. One day after transfection, the fluorescence intensity 
histogram (E) and mean fluorescence intensity (F) of cells were analyzed by flow cytometry. The 
results are expressed as the mean ± SD (n = 4). *P < 0.05. 
 
Fig.3. Effect of cotransfection on the levels of mRNA and protein in B16-BL6 cells. A & B. 
B16-BL6 cells were cotransfected with 1.8 μg/ml pRL-TK (closed bar), pRL-SV40 (open bar) or 
pRL-CMV (grey bar) and 0.2 μg/ml pFL-CMV. One day after transfection, mRNA and protein 
expression levels of renilla (A) and firefly (B) luciferase were simultaneously measured. The 
results are expressed as the mean ± SD (n = 4). *P < 0.05. 
  
Fig.4. Effect of siRNA-mediated degradation of mRNA expressed from the competing 
plasmid on the expression from the monitoring plasmid. A & B. B16-BL6 cells were 
cotransfected with siGFP (closed bar) or siRL (open bar) (1 μg/ml), 0.9 μg/ml pRL-CMV, 
pRL-SV40 or pRL-TK and 0.1 μg/ml pFL-CMV. One day after transfection, renilla (A) and 
firefly (B) luciferase activities were simultaneously measured. The results are expressed as the 
mean ± SD (n = 4). *P < 0.05. 
 
Fig.5. Effect of level of transgene expression from competing plasmid DNA on the 
expression from monitoring plasmid DNA and endogenous gene in mouse liver. A. Mice 
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received a hydrodynamic injection of pFL-CMV at indicated doses. At 6 hr after injection, the 
level of mRNA (open triangle) and protein (closed circle) expression of firefly luciferase were 
simultaneously measured. The results are expressed as the mean + SD (n = 4). B. The amount of 
mRNA or protein expression in Fig. 5A was divided by the dose. The results are expressed as the 
mean + SD of the relative value to that of 1 μg group (n = 4). *P < 0.05 vs 1 μg group. C. Mice 
received a hydrodynamic injection of 0 (hatched bar), 1 (open bar), or 100μg pFL-CMV (grey 
bar) or were untreated (closed bar). At 6 hr after injection, the level of mRNA and protein 
expression of firefly luciferase and GAPDH were simultaneously measured. The results are 
expressed as mean ± SD of the relative value to that of GAPDH of the no treatment groups (n = 
4). D & E. Mice received a hydrodynamic injection of 1 μg pRL-CMV and 10 μg pFL-TATA 
(closed bar), pFL-SV40 (open bar) or pFL-CMV (grey bar). At 6 hr after injection, mRNA and 
protein expression of firefly (C) and renilla (D) luciferase were simultaneously measured. The 
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